JP2020534284A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020534284A5 JP2020534284A5 JP2020515680A JP2020515680A JP2020534284A5 JP 2020534284 A5 JP2020534284 A5 JP 2020534284A5 JP 2020515680 A JP2020515680 A JP 2020515680A JP 2020515680 A JP2020515680 A JP 2020515680A JP 2020534284 A5 JP2020534284 A5 JP 2020534284A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- composition according
- rsv
- composition
- proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 claims 16
- 102000004169 proteins and genes Human genes 0.000 claims 16
- 241000725643 Respiratory syncytial virus Species 0.000 claims 13
- 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 claims 6
- 108091006027 G proteins Proteins 0.000 claims 3
- 102000030782 GTP binding Human genes 0.000 claims 3
- 108091000058 GTP-Binding Proteins 0.000 claims 3
- 239000013603 viral vector Substances 0.000 claims 3
- 101150039699 M2-1 gene Proteins 0.000 claims 2
- 101710141454 Nucleoprotein Proteins 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 2
- 229960005486 vaccine Drugs 0.000 claims 2
- 101100507655 Canis lupus familiaris HSPA1 gene Proteins 0.000 claims 1
- 241000711975 Vesicular stomatitis virus Species 0.000 claims 1
- 230000004927 fusion Effects 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 239000013598 vector Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762559167P | 2017-09-15 | 2017-09-15 | |
| US62/559,167 | 2017-09-15 | ||
| PCT/US2018/051054 WO2019055768A1 (en) | 2017-09-15 | 2018-09-14 | VACCINES AND METHODS OF MAKING AND USING VACCINES FOR THE PREVENTION OF SYNCYTIAL RESPIRATORY VIRUS (RSV) INFECTIONS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020534284A JP2020534284A (ja) | 2020-11-26 |
| JP2020534284A5 true JP2020534284A5 (enExample) | 2021-10-21 |
Family
ID=65723867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020515680A Pending JP2020534284A (ja) | 2017-09-15 | 2018-09-14 | ワクチン、並びに、呼吸器合胞体ウイルス（ｒｓｖ）感染症を予防するためのワクチンの作製方法及び使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20200276297A1 (enExample) |
| EP (1) | EP3681523A4 (enExample) |
| JP (1) | JP2020534284A (enExample) |
| KR (1) | KR20200096904A (enExample) |
| CN (1) | CN111344008A (enExample) |
| AU (1) | AU2018331467A1 (enExample) |
| CA (1) | CA3075990A1 (enExample) |
| WO (1) | WO2019055768A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7657727B2 (ja) | 2019-04-02 | 2025-04-07 | サノフイ | 抗原性多量体呼吸器合胞体ウイルスポリペプチド |
| CN112226450B (zh) * | 2020-08-25 | 2022-10-14 | 北京交通大学 | 一种共表达呼吸道合胞病毒融合前蛋白和黏附糖蛋白的复制缺陷型腺病毒载体疫苗 |
| KR20230047033A (ko) * | 2021-09-29 | 2023-04-06 | 에스케이바이오사이언스(주) | 재조합된 약독화 rsv 생백신 및 이를 제조하는 방법 |
| KR102806300B1 (ko) * | 2023-01-13 | 2025-05-14 | 클립스비엔씨 주식회사 | 호흡기 신시치아 바이러스 변이체를 포함하는 호흡기 신시치아 바이러스 백신용 융합단백질 및 이의 제조방법 |
| CN118930654A (zh) * | 2023-05-12 | 2024-11-12 | 中国科学院微生物研究所 | 一种呼吸道合胞病毒抗原制备方法和应用 |
| CN117720628A (zh) * | 2023-10-12 | 2024-03-19 | 中国科学院微生物研究所 | 一种呼吸道合胞病毒二价抗原制备方法和应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1224462A (zh) * | 1996-07-15 | 1999-07-28 | 美国政府健康及人类服务部 | 从克隆的核苷酸序列制备减毒呼吸道合胞病毒疫苗的方法 |
| IL145797A0 (en) * | 1999-04-13 | 2002-07-25 | Government Of The Us Dept Of H | Production of attenuated negative stranded rna virus vaccines from cloned nucleotide sequences |
| AU2001264824A1 (en) * | 2000-06-01 | 2001-12-11 | St. Jude Children's Research Hospital | Vaccine and gene therapy vector and methods of use thereof |
| US20050048030A1 (en) * | 2001-09-28 | 2005-03-03 | Raymond Pickles | Paramyxoviruses as gene transfer vectors to lung cells |
| TWI344991B (en) * | 2002-02-21 | 2011-07-11 | Medimmune Vaccines Inc | Metapneumovirus strains as vaccine formulations and as vectors for expression of heterologous antigenic sequences |
| EP1527087B2 (en) * | 2002-07-26 | 2013-07-17 | Her Majesty, The Queen in Right of Canada, as Represented by The Minister of Health | Recombinant vesicular stomatitis virus vaccines for viral hemorrhagic fevers |
| WO2004113517A2 (en) * | 2003-06-09 | 2004-12-29 | Wyeth | IMPROVED METHOD FOR THE RECOVERY OF NON-SEGMENTED, NEGATIVE-STRANDED RNA VIRUSES FROM cDNA |
| US7585667B2 (en) * | 2003-06-13 | 2009-09-08 | The United States Of America As Represented By The Department Of Health And Human Services | Negative strand RNA virus replicon |
| EP1756287B1 (en) * | 2004-04-09 | 2015-02-25 | Wyeth LLC | Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof |
| WO2008133663A2 (en) * | 2006-11-30 | 2008-11-06 | Government Of The United States Of America, As Represented By The Secretary, | Codon modified immunogenic compositions and methods of use |
| US20090092635A1 (en) * | 2007-08-17 | 2009-04-09 | Wyeth | Heterologous prime-boost immunization regimen |
| US20090162321A1 (en) * | 2007-12-20 | 2009-06-25 | Wyeth | Methods for packaging propagation-defective vesicular stomatitis virus vectors using a stable cell line that expresses g protein |
| BRPI0921424A2 (pt) * | 2008-11-05 | 2016-01-05 | Merck Sharp & Dohme | vírus sincicial respiratório atenuado, composição imunogênica, molécula de ácido nucléico, célula recombinante, método para produzir uma resposta imune protetiva em um paciente, e, uso de uma quantidade imunologicamente eficaz de um ou mais dos seguintes: um rsv atenuado, uma população de rsv atenuado e uma composição imunogênica. |
| AU2015225553B2 (en) * | 2014-03-01 | 2020-02-27 | Profectus Biosciences, Inc. | Recombinant Isfahan viral vectors |
| EP3154576A1 (en) * | 2014-06-13 | 2017-04-19 | GlaxoSmithKline Biologicals S.A. | Immunogenic combinations |
-
2018
- 2018-09-14 EP EP18856392.8A patent/EP3681523A4/en not_active Withdrawn
- 2018-09-14 WO PCT/US2018/051054 patent/WO2019055768A1/en not_active Ceased
- 2018-09-14 KR KR1020207010971A patent/KR20200096904A/ko not_active Ceased
- 2018-09-14 US US16/647,758 patent/US20200276297A1/en not_active Abandoned
- 2018-09-14 AU AU2018331467A patent/AU2018331467A1/en not_active Abandoned
- 2018-09-14 CA CA3075990A patent/CA3075990A1/en active Pending
- 2018-09-14 CN CN201880073897.7A patent/CN111344008A/zh active Pending
- 2018-09-14 JP JP2020515680A patent/JP2020534284A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020022459A5 (enExample) | ||
| PH12018501912A1 (en) | Vaccine against rsv | |
| JP2015096070A5 (enExample) | ||
| JP2017048194A5 (enExample) | ||
| CN106659777A8 (zh) | 免疫原性组合产品 | |
| JP2013507907A5 (enExample) | ||
| JP2016146837A5 (enExample) | ||
| WO2014205579A4 (en) | Modified matrix proteins of vesicular stomatitis virus | |
| ATE419369T1 (de) | Chimäre mensch-rinder respiratory syncytial virus vakzinen | |
| JP2014502156A5 (enExample) | ||
| JP2015533841A5 (enExample) | ||
| JP2014503206A5 (enExample) | ||
| JP2016052331A5 (enExample) | ||
| JP2016533332A5 (enExample) | ||
| JP2008500399A5 (enExample) | ||
| JP2009544333A5 (enExample) | ||
| JP2015501840A5 (enExample) | ||
| JP2010535026A5 (enExample) | ||
| JP2015509707A5 (enExample) | ||
| EA202090738A1 (ru) | Способ безопасного индуцирования иммунитета против rsv | |
| JP2023100654A5 (enExample) | ||
| JP2010508030A5 (enExample) | ||
| JP2019214579A5 (enExample) | ||
| RU2013120979A (ru) | Северо-американский вирус репродуктивно-респираторного синдрома свиней (prrs) и его применения | |
| JP2013502225A5 (enExample) |